The Experts below are selected from a list of 393 Experts worldwide ranked by ideXlab platform

Mark Goodfield - One of the best experts on this subject based on the ideXlab platform.

  • puva therapy in Lichen Aureus
    Journal of The American Academy of Dermatology, 2001
    Co-Authors: T.c. Ling, V. Goulden, Mark Goodfield
    Abstract:

    Abstract Lichen Aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of Lichen Aureus that responded dramatically to photochemotherapy (PUVA). (J Am Acad Dermatol 2001;45:145-6.)

  • PUVA therapy in Lichen Aureus.
    Journal of the American Academy of Dermatology, 2001
    Co-Authors: T.c. Ling, V. Goulden, Mark Goodfield
    Abstract:

    Lichen Aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of Lichen Aureus that responded dramatically to photochemotherapy (PUVA).

Jeung-hoon Lee - One of the best experts on this subject based on the ideXlab platform.

T.c. Ling - One of the best experts on this subject based on the ideXlab platform.

  • puva therapy in Lichen Aureus
    Journal of The American Academy of Dermatology, 2001
    Co-Authors: T.c. Ling, V. Goulden, Mark Goodfield
    Abstract:

    Abstract Lichen Aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of Lichen Aureus that responded dramatically to photochemotherapy (PUVA). (J Am Acad Dermatol 2001;45:145-6.)

  • PUVA therapy in Lichen Aureus.
    Journal of the American Academy of Dermatology, 2001
    Co-Authors: T.c. Ling, V. Goulden, Mark Goodfield
    Abstract:

    Lichen Aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of Lichen Aureus that responded dramatically to photochemotherapy (PUVA).

Lorenzo Cerroni - One of the best experts on this subject based on the ideXlab platform.

  • Lichen Aureus clinicopathologic features natural history and relationship to mycosis fungoides
    Archives of Dermatology, 2008
    Co-Authors: Regina Finkpuches, Peter Wolf, Helmut Kerl, Lorenzo Cerroni
    Abstract:

    Background A possible association between Lichen Aureus (LA) and mycosis fungoides (MF) has been suggested in the past. We evaluated the clinicopathologic features of LA and its relationship to MF. Data from 23 patients with a clinicopathologic diagnosis of LA were reviewed. Observations Lesions were asymmetrically localized on 1 area of the body (mostly 1 extremity) and were characterized histologically by dense, bandlike lymphocytic infiltrates. A monoclonal T-cell population was detected in half of the cases. After a mean follow-up of 102.1 months, 14 patients had no sign of skin disease, 7 patients had unmodified skin lesions, and 2 other patients with unmodified skin lesions had died of unrelated conditions. Treatment modalities did not affect the outcome. There was no relationship between the presence or absence of monoclonality and patient status at follow-up assessments. Conclusion Patients with classic lesions of LA do not show progression to MF.

Dong-kyun Hong - One of the best experts on this subject based on the ideXlab platform.